JP2022542937A5 - - Google Patents
Info
- Publication number
- JP2022542937A5 JP2022542937A5 JP2022505602A JP2022505602A JP2022542937A5 JP 2022542937 A5 JP2022542937 A5 JP 2022542937A5 JP 2022505602 A JP2022505602 A JP 2022505602A JP 2022505602 A JP2022505602 A JP 2022505602A JP 2022542937 A5 JP2022542937 A5 JP 2022542937A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- methyl
- propyl
- benzothiazole
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19188747.0 | 2019-07-29 | ||
| EP19188747 | 2019-07-29 | ||
| PCT/EP2020/071179 WO2021018857A1 (en) | 2019-07-29 | 2020-07-28 | 3,6-diamino-pyridazin-3-yl derivatives, pharmaceutical compositions containing them and their uses as pro-apoptotic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022542937A JP2022542937A (ja) | 2022-10-07 |
| JP2022542937A5 true JP2022542937A5 (https=) | 2023-07-14 |
| JP7646626B2 JP7646626B2 (ja) | 2025-03-17 |
Family
ID=67514281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022505602A Active JP7646626B2 (ja) | 2019-07-29 | 2020-07-28 | ３，６－ジアミノ－ピリダジン－３－イル誘導体、それを含有する医薬組成物及びアポトーシス促進剤としてのその使用 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20220289734A1 (https=) |
| EP (1) | EP4003988A1 (https=) |
| JP (1) | JP7646626B2 (https=) |
| KR (1) | KR20220042182A (https=) |
| CN (1) | CN114450283B (https=) |
| AR (1) | AR119493A1 (https=) |
| AU (1) | AU2020322072A1 (https=) |
| BR (1) | BR112022001330A2 (https=) |
| CA (1) | CA3148502A1 (https=) |
| CL (1) | CL2021003594A1 (https=) |
| CO (1) | CO2022000700A2 (https=) |
| CR (1) | CR20220014A (https=) |
| DO (1) | DOP2022000015A (https=) |
| GE (2) | GEAP202415866A (https=) |
| IL (1) | IL289932B2 (https=) |
| JO (1) | JOP20220006A1 (https=) |
| MX (1) | MX2022001161A (https=) |
| PE (1) | PE20220704A1 (https=) |
| PH (1) | PH12022550018A1 (https=) |
| PY (1) | PY2039849A (https=) |
| SA (1) | SA522431498B1 (https=) |
| TW (1) | TWI900486B (https=) |
| UY (1) | UY38809A (https=) |
| WO (1) | WO2021018857A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021386367A1 (en) * | 2020-11-24 | 2023-06-22 | Les Laboratoires Servier | Bcl-xl inhibitor antibody-drug conjugates and methods of use thereof |
| JP2024505562A (ja) * | 2021-02-02 | 2024-02-06 | レス ラボラトイレス セルビエル | 選択的ｂｃｌ－ｘｌ ｐｒｏｔａｃ化合物及び使用の方法 |
| CN119562832A (zh) | 2022-05-20 | 2025-03-04 | 诺华股份有限公司 | Met bcl-xl抑制剂抗体-药物缀合物及其使用方法 |
| AU2023271885A1 (en) | 2022-05-20 | 2024-12-12 | Les Laboratoires Servier | Epha2 bcl-xl inhibitor antibody-drug conjugates and methods of use thereof |
| US20250387504A1 (en) | 2022-05-20 | 2025-12-25 | Novartis Ag | Antibody-drug conjugates of antineoplastic compounds and methods of use thereof |
| PY24103486A (es) | 2023-11-22 | 2025-06-06 | Servier Lab | Conjugados de anticuerpo anti-cd74-fármaco y métodos de uso de los mismos |
| AR134424A1 (es) | 2023-11-22 | 2026-01-14 | Novartis Ag | Conjugados de anticuerpo anti-cd7-fármaco y métodos de uso de los mismos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003059354A2 (en) * | 2001-12-21 | 2003-07-24 | Bayer Pharmaceuticals Corporation | Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives |
| WO2009020603A2 (en) * | 2007-08-08 | 2009-02-12 | The Scripps Research Institute | Upp amphiphilic alpha-helix mimetics |
| EA201001030A1 (ru) * | 2007-12-19 | 2011-02-28 | Амген Инк. | Конденсированные соединения пиридина, пиримидина и триазина в качестве ингибиторов клеточного цикла |
| FR3015483B1 (fr) | 2013-12-23 | 2016-01-01 | Servier Lab | Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| SG11201709837RA (en) * | 2015-05-29 | 2017-12-28 | Teijin Pharma Ltd | PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF |
-
2020
- 2020-07-27 AR ARP200102095A patent/AR119493A1/es unknown
- 2020-07-28 MX MX2022001161A patent/MX2022001161A/es unknown
- 2020-07-28 US US17/630,655 patent/US20220289734A1/en active Pending
- 2020-07-28 TW TW109125418A patent/TWI900486B/zh active
- 2020-07-28 JP JP2022505602A patent/JP7646626B2/ja active Active
- 2020-07-28 CN CN202080068042.2A patent/CN114450283B/zh active Active
- 2020-07-28 CA CA3148502A patent/CA3148502A1/en active Pending
- 2020-07-28 KR KR1020227006624A patent/KR20220042182A/ko active Pending
- 2020-07-28 IL IL289932A patent/IL289932B2/en unknown
- 2020-07-28 PY PY202002039849A patent/PY2039849A/es unknown
- 2020-07-28 CR CR20220014A patent/CR20220014A/es unknown
- 2020-07-28 UY UY0001038809A patent/UY38809A/es unknown
- 2020-07-28 AU AU2020322072A patent/AU2020322072A1/en active Pending
- 2020-07-28 GE GEAP202415866A patent/GEAP202415866A/en unknown
- 2020-07-28 GE GEAP202015866A patent/GEP20247670B/en unknown
- 2020-07-28 JO JOP/2022/0006A patent/JOP20220006A1/ar unknown
- 2020-07-28 PE PE2022000148A patent/PE20220704A1/es unknown
- 2020-07-28 BR BR112022001330A patent/BR112022001330A2/pt unknown
- 2020-07-28 WO PCT/EP2020/071179 patent/WO2021018857A1/en not_active Ceased
- 2020-07-28 PH PH1/2022/550018A patent/PH12022550018A1/en unknown
- 2020-07-28 EP EP20749833.8A patent/EP4003988A1/en active Pending
-
2021
- 2021-12-30 CL CL2021003594A patent/CL2021003594A1/es unknown
-
2022
- 2022-01-25 DO DO2022000015A patent/DOP2022000015A/es unknown
- 2022-01-26 CO CONC2022/0000700A patent/CO2022000700A2/es unknown
- 2022-01-26 SA SA522431498A patent/SA522431498B1/ar unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022542937A5 (https=) | ||
| JP2021512059A5 (https=) | ||
| CN114430739A (zh) | Egfr抑制剂、组合物及其制备方法 | |
| JP2023123854A5 (https=) | ||
| JP2019535746A5 (https=) | ||
| JP2019535744A5 (https=) | ||
| JP2021529812A5 (https=) | ||
| CA2651363A1 (en) | Triazolopyrazine derivatives useful as anti-cancer agents | |
| JP2022520448A5 (https=) | ||
| JP2022547952A5 (https=) | ||
| HRP20240392T1 (hr) | 6,7-dihidro-5h-pirido[2,3-c] derivati piridazina i srodni spojevi kao inhibitori bcl-xl proteina i pro-apoptozna sredstva za liječenje raka | |
| JP2024501641A5 (https=) | ||
| JP2018510857A5 (https=) | ||
| RU2013153540A (ru) | Аминопиридинсодержащие ингибиторы тирозинкиназы селезенки (syk) | |
| BR112016018062B1 (pt) | Compostos terapêuticos, composição farmacêutica e usos | |
| JP2008504266A5 (https=) | ||
| RU2021102253A (ru) | Деструкторы белка mdm2 | |
| JP2007505922A5 (https=) | ||
| JP2007538092A5 (https=) | ||
| JP2009520685A5 (https=) | ||
| JP2021502387A5 (https=) | ||
| JP2020534373A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| JP2012505916A5 (https=) | ||
| JP2010538094A5 (https=) |